Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Nephrology · Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis

Standard of Care Treatment and Symptom Management

At a Glance

FHHNC treatment is supportive, not curative: prescribed fluids, magnesium replacement, and carefully monitored medicines help manage symptoms and kidney stone risk, but they do not reliably stop kidney function from declining. Advanced kidney failure may require a transplant.

Managing FHHNC is a balancing act. Because the underlying genetic defect cannot currently be fixed, medical care is supportive [1]. This means your treatment plan is designed to replace what the kidneys are losing, manage symptoms like muscle cramps, and slow the progression of kidney damage as much as possible [1][2].

However, supportive care must be strictly individualized. Medications and fluid targets require close monitoring by a nephrologist.

The Foundation: Individualized Fluid Intake

One of the most important aspects of managing FHHNC is drinking sufficient water. Because your kidneys cannot concentrate urine effectively, you lose a significant amount of fluid every day (polyuria) [3].

  • Diluting the Urine: Adequate fluid intake helps keep the urine diluted, which reduces the concentration of calcium. This can help prevent the formation of new kidney stones and may slow the buildup of nephrocalcinosis (calcium deposits) in the kidney tissue [1][4].
  • Targeted Hydration: There is no one-size-fits-all “large amount” of water. Your nephrologist must prescribe a safe fluid target based on age, body size, urine output, kidney function, and heart status. Forcing fluids or drinking excessive plain water can cause dangerous electrolyte dilution (hyponatremia) or fluid overload, particularly as CKD advances.
  • Sick-Day Plan: Patients with FHHNC can become dehydrated very quickly. You must have a clinician-approved sick-day plan for illnesses with fever, vomiting, or diarrhea.

Magnesium Supplementation

The goal of taking magnesium is to raise blood levels enough to stop symptoms like muscle twitches, cramps, or—in severe cases—seizures [5]. However, this is often difficult to achieve.

  • The Dosage Challenge: To raise blood levels, very high doses of magnesium are often required. However, these high doses frequently cause diarrhea [6].
  • The Paradox: Diarrhea can actually cause you to lose more magnesium and fluid through your digestive tract, potentially making your levels drop further [6].
  • Alternative Options: The appropriate dose depends on “elemental” magnesium. If traditional magnesium salts (like magnesium oxide or pidolate) are not well-tolerated, some case reports suggest sucrosomial magnesium might be easier on the stomach, though it is not a universally established standard [6][7]. Never stop or substitute magnesium formulations without your nephrologist’s advice. In emergencies where levels are dangerously low, intravenous (IV) magnesium is a clinical treatment administered by professionals.

Managing Calcium and Stone Risk

To address the high levels of calcium in the urine (hypercalciuria), doctors may consider specific medications, though they are not universal standards and carry risks:

  1. Thiazide Diuretics: Medications like hydrochlorothiazide are sometimes considered to help the kidneys reabsorb more calcium, reducing the amount that ends up in the urine [3]. They are sometimes combined with amiloride. However, they can cause volume depletion (dehydration), dangerously low sodium, low blood pressure, and potassium changes [3]. They require strict individualized monitoring of blood pressure, creatinine, sodium, potassium, magnesium, and bicarbonate.
  2. Citrate Therapy: Potassium citrate is sometimes prescribed to help prevent calcium from crystallizing into stones [8][3]. Citrate acts as a “stone inhibitor” [4]. However, as kidney function declines, potassium citrate can cause dangerous spikes in blood potassium.

Limits of Current Treatment

It is important to understand that while these treatments help manage symptoms, they have significant limitations. Research reviews have noted that even with consistent magnesium and thiazide therapy, many patients do not see a significant improvement in their blood magnesium levels or a major reduction in urine calcium [2].

Most critically, these supportive treatments have not been proven to definitively stop the long-term decline in kidney function [2]. FHHNC remains a progressive condition that can lead to Chronic Kidney Disease (CKD) or kidney failure over time [2][9]. Because of this, the most effective long-term treatment for advanced kidney failure in FHHNC remains a kidney transplant [1][2]. Regular monitoring is essential to track how your kidneys are performing and to safely adjust your supportive care [5].

Common questions in this guide

What is the main treatment for FHHNC?
FHHNC is managed with supportive care because current treatment cannot correct the underlying genetic kidney defect. Care may include a prescribed fluid target, magnesium replacement, medicines for high urine calcium or stone risk, and regular blood and kidney tests.
How much water should I drink with FHHNC?
Your nephrologist sets a daily fluid target using your age, body size, urine output, kidney function, and heart status. Do not force large amounts of plain water, because too much can dilute blood sodium or cause fluid overload, especially when kidney disease is advanced.
Why can magnesium treatment be difficult in FHHNC?
High doses of magnesium are often needed to raise blood levels, but they commonly cause diarrhea. Diarrhea can increase magnesium and fluid losses, so your nephrologist may change the amount or product; intravenous magnesium is given by medical professionals when levels are dangerously low.
Can medicines reduce kidney stone risk in FHHNC?
Thiazide medicines such as hydrochlorothiazide may lower the amount of calcium lost in urine, and potassium citrate may help keep calcium from forming stones. These medicines are not right for everyone and can affect blood pressure, sodium, potassium, magnesium, or kidney function, so they require close monitoring.
Will treatment stop FHHNC from worsening kidney function?
Supportive treatment can manage fluid loss, low magnesium, and stone risk, but it has not been proven to stop FHHNC from causing long-term kidney damage. The condition may progress to chronic kidney disease or kidney failure, and a kidney transplant is the main long-term treatment when kidney failure is advanced.
What should I do if illness causes vomiting or diarrhea with FHHNC?
People with FHHNC can become dehydrated quickly during fever, vomiting, or diarrhea. Ask your care team for a written sick-day plan before illness occurs; it should explain fluids, medicines, and when to seek urgent help if oral magnesium or fluids cannot stay down.

Get notified when new evidence is published on Primary hypomagnesemia with hypercalciuria and nephrocalcinosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

    Vall-Palomar M, Madariaga L, Ariceta G

    Pediatric nephrology (Berlin, Germany) 2021; (36(10)):3045-3055 doi:10.1007/s00467-021-04968-2.

    PMID: 33595712
  2. 2

    Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics.

    Claverie-Martin F

    Clinical kidney journal 2015; (8(6)):656-64 doi:10.1093/ckj/sfv081.

    PMID: 26613020
  3. 3

    Hypomagnesemia with Hypercalciuria Leading to Nephrocalcinosis, Amelogenesis Imperfecta, and Short Stature in a Child Carrying a Homozygous Deletion in the CLDN16 Gene.

    Radonsky V, Kizys MML, Dotto RP, et al.

    Calcified tissue international 2020; (107(4)):403-408 doi:10.1007/s00223-020-00726-y.

    PMID: 32710267
  4. 4

    Recurrent Nephrolithiasis and Beyond: The Long Diagnostic Odyssey of a Case of CLDN16 Mutation.

    Bhuiyan AAN, Akter N, Haq T, et al.

    Clinical case reports 2025; (13(12)):e71530 doi:10.1002/ccr3.71530.

    PMID: 41306405
  5. 5

    Whole exome sequencing reveals a pathogenic homozygous CLDN16 mutation in a 17-year-old patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis: A case report.

    Wang F, Adeerjiang Y, Xing HQ, Jiang S

    Medicine 2025; (104(33)):e43839 doi:10.1097/MD.0000000000043839.

    PMID: 40826740
  6. 6

    Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis: A Case Report of Compound Heterozygous Variants in the CLDN16 Gene Inherited From Symptomatic Heterozygous Carriers.

    Ceol M, Sgrò E, Anglani F, et al.

    Case reports in nephrology and dialysis 2026; (16(1)):162-170 doi:10.1159/cnd/abxag006.

    PMID: 42960388
  7. 7

    Compounded Effervescent Magnesium for Familial Hypomagnesemia: A Case Report.

    Bennati G, Cirino M, Benericetti G, et al.

    Pharmaceuticals (Basel, Switzerland) 2023; (16(6)) doi:10.3390/ph16060785.

    PMID: 37375733
  8. 8

    Familial Hypomagnesemia, Hypercalciuria and Nephrocalcinosis with Novel Mutation.

    Margabandhu S, Doshi M

    Indian journal of nephrology 2019; (29(1)):57-61 doi:10.4103/ijn.IJN_323_17.

    PMID: 30814796
  9. 9

    Hypertensive emergency due to a delayed dialysis modality transition in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis: a case report.

    Woszczyk D, Płonka M, Różańska M, et al.

    European review for medical and pharmacological sciences 2024; (28(9)):3313-3317 doi:10.26355/eurrev_202405_36177.

    PMID: 38766789

This page is for informational purposes only and does not constitute medical advice. A nephrologist should individualize your fluid, magnesium, medication, and monitoring plan for FHHNC.